Explore more publications!
Health Observer Falkland Islands
Got News to Share?

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on February 27, 2026

Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
Feb. 27, 2026

Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference

Indeterminate GlobeNewswire
Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial
Feb. 27, 2026

Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial

Indeterminate GlobeNewswire
A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
Feb. 27, 2026

A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

Indeterminate GlobeNewswire
LeMaitre to Participate at Upcoming Investor Conferences in March
Feb. 27, 2026

LeMaitre to Participate at Upcoming Investor Conferences in March

Indeterminate GlobeNewswire
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at…
Feb. 27, 2026

Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at…

Indeterminate GlobeNewswire
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Feb. 27, 2026

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

Indeterminate GlobeNewswire
AshtonManual.org Launches as the Definitive Resource for Safe, Evidence-Based Benzodiazepine Tapering
Feb. 27, 2026

AshtonManual.org Launches as the Definitive Resource for Safe, Evidence-Based Benzodiazepine Tapering

Indeterminate GlobeNewswire
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Feb. 27, 2026

ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Indeterminate GlobeNewswire
Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States
Feb. 27, 2026

Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States

Indeterminate GlobeNewswire
Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
Feb. 27, 2026

Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting

Indeterminate GlobeNewswire
The Standard Process Brand Evolution Elevates Awareness of Whole Food Nutrition
Feb. 27, 2026

The Standard Process Brand Evolution Elevates Awareness of Whole Food Nutrition

Indeterminate GlobeNewswire
Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month
Feb. 27, 2026

Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month

Indeterminate GlobeNewswire
Global Proteomics Services Market to Reach USD 16.46 Billion by 2030 | MarketsandMarkets™
Feb. 27, 2026

Global Proteomics Services Market to Reach USD 16.46 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
New Study Finds Half of Americans Don’t Know You Can Screen for Colorectal Cancer at Home
Feb. 27, 2026

New Study Finds Half of Americans Don’t Know You Can Screen for Colorectal Cancer at Home

Indeterminate GlobeNewswire
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
Feb. 27, 2026

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Indeterminate GlobeNewswire
ESO Wave Convenes Emergency Services and Healthcare Leaders To Advance Data-Driven Outcomes
Feb. 27, 2026

ESO Wave Convenes Emergency Services and Healthcare Leaders To Advance Data-Driven Outcomes

Indeterminate GlobeNewswire
Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts
Feb. 27, 2026

Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts

Indeterminate GlobeNewswire
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
Feb. 27, 2026

AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering

Indeterminate GlobeNewswire
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
Feb. 27, 2026

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

Indeterminate GlobeNewswire
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Feb. 27, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions